Author Information
Alexander Herrmann Enk is a distinguished researcher affiliated with the Department of Dermatology at Ruprecht Karls University in Heidelberg, Germany. His research primarily focuses on dermatology, with notable contributions in the study and treatment of melanoma, immunotherapy, and skin cancer detection. His work is widely recognized and cited in the field of dermatology.Research Contributions
Alexander Herrmann Enk has made significant contributions to the field of dermatology, as evidenced by his extensive publication record. His recent works from 2022 include studies on the sequence of radio-immunotherapy for melanoma brain metastases, training and retaining physician-scientists in dermatology in Germany, and subcutaneous panniculitis-like T-cell lymphoma. He has also investigated the use of MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma, analyzed sex-related differences in skin cancer detection using convolutional neural networks, and contributed to the treatment of actinic keratoses in organ transplant recipients. Furthermore, his work includes the evaluation of Psoriasis Area and Severity Index thresholds and the monitoring of patients at risk for melanoma using advanced neural networks.Aliases
Alexander Herrmann Enk is also known by several aliases in his publications, including Alexander\u2004h. Enk, Alexander Enk, A. H. Enk, A.h. Enk, Alexander H Enk, Alexander H. Enk, A H Enk, A. Enk, and A Enk.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
27,898 |
| h-index |
72 |
| Paper Count |
527 |
